We used a comprehensive dataset comprising 263 bulk RNAseq CLL samples from the ICGC cohort without genetic alterations in MYC (Knisbacher et al., 2022), along with 12 samples from 6 CLL patients pre- and post-RT (Nadeu et al., 2022). Here, MYC is linked to B-cell chronic lymphocytic leukemia.